» Articles » PMID: 34571805

Mitochondrial Heterogeneity in Metabolic Diseases

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2021 Sep 28
PMID 34571805
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria have distinct architectural features and biochemical functions consistent with cell-specific bioenergetic needs. However, as imaging and isolation techniques advance, heterogeneity amongst mitochondria has been observed to occur within the same cell. Moreover, mitochondrial heterogeneity is associated with functional differences in metabolic signaling, fuel utilization, and triglyceride synthesis. These phenotypic associations suggest that mitochondrial subpopulations and heterogeneity influence the risk of metabolic diseases. This review examines the current literature regarding mitochondrial heterogeneity in the pancreatic beta-cell and renal proximal tubules as they exist in the pathological and physiological states; specifically, pathological states of glucolipotoxicity, progression of type 2 diabetes, and kidney diseases. Emphasis will be placed on the benefits of balancing mitochondrial heterogeneity and how the disruption of balancing heterogeneity leads to impaired tissue function and disease onset.

Citing Articles

Mitochondrial heterogeneity: subpopulations with distinct metabolic activities.

den Brave F, Mishra S, Becker T Signal Transduct Target Ther. 2025; 10(1):36.

PMID: 39915451 PMC: 11802894. DOI: 10.1038/s41392-025-02130-0.


Transitions from Aerobic to Anaerobic Metabolism and Oxygen Debt during Elective Major and Emergency Non-Cardiac Surgery.

Papagiannakis N, Ragias D, Ntalarizou N, Laou E, Kyriakaki A, Mavridis T Biomedicines. 2024; 12(8).

PMID: 39200218 PMC: 11351305. DOI: 10.3390/biomedicines12081754.


PIEZO1 targeting in macrophages boosts phagocytic activity and foam cell apoptosis in atherosclerosis.

Pourteymour S, Fan J, Majhi R, Guo S, Sun X, Huang Z Cell Mol Life Sci. 2024; 81(1):331.

PMID: 39107572 PMC: 11335255. DOI: 10.1007/s00018-024-05372-3.


Nanobiopsy investigation of the subcellular mtDNA heteroplasmy in human tissues.

Bury A, Pyle A, Vincent A, Actis P, Hudson G Sci Rep. 2024; 14(1):13789.

PMID: 38877095 PMC: 11178779. DOI: 10.1038/s41598-024-64455-0.


Microcirculation-driven mitochondrion dysfunction during the progression of experimental sepsis.

Fejes R, Rutai A, Juhasz L, Poles M, Szabo A, Kaszaki J Sci Rep. 2024; 14(1):7153.

PMID: 38531957 PMC: 10966066. DOI: 10.1038/s41598-024-57855-9.


References
1.
Gottlieb R, Stotland A . MitoTimer: a novel protein for monitoring mitochondrial turnover in the heart. J Mol Med (Berl). 2014; 93(3):271-8. PMC: 4333239. DOI: 10.1007/s00109-014-1230-6. View

2.
Nolan C, Madiraju M, Delghingaro-Augusto V, Peyot M, Prentki M . Fatty acid signaling in the beta-cell and insulin secretion. Diabetes. 2006; 55 Suppl 2:S16-23. DOI: 10.2337/db06-s003. View

3.
Kuznetsov A, Margreiter R . Heterogeneity of mitochondria and mitochondrial function within cells as another level of mitochondrial complexity. Int J Mol Sci. 2009; 10(4):1911-1929. PMC: 2680654. DOI: 10.3390/ijms10041911. View

4.
Beraud N, Pelloux S, Usson Y, Kuznetsov A, Ronot X, Tourneur Y . Mitochondrial dynamics in heart cells: very low amplitude high frequency fluctuations in adult cardiomyocytes and flow motion in non beating Hl-1 cells. J Bioenerg Biomembr. 2009; 41(2):195-214. DOI: 10.1007/s10863-009-9214-x. View

5.
Bitar M, Al-Saleh E, Al-Mulla F . Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes. Life Sci. 2005; 77(20):2552-73. DOI: 10.1016/j.lfs.2005.01.033. View